Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis

For many patients with hematologic malignancies or nonmalignant diseases, allogeneic hematopoietic cell transplantation (alloHCT) is the preferred treatment option. Numerous factors influence whether a patient eligible for transplantation actually go on to undergo transplantation. Patients need to have a disease status that renders them eligible for alloHCT, have suitable performance status and organ function, and have an available donor. In addition, various sociodemographic variables, such as insurance coverage, might impair access to alloHCT [1].

Source: Biology of Blood and Marrow Transplantation - June 18, 2019 Category: Hematology Authors: Kristjan Paulson, Ruta Brazauskas, Nandita Khera, Naya He, Navneet Majhail, Gorgun Akpek, Mahmoud Aljurf, David Buchbinder, Linda Burns, Sara Beattie, Cesar Freytes, Anne Garcia, James Gajewski, Theresa Hahn, Jennifer Knight, Charles LeMaistre, Hillard La Source Type: research